Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/9 | 9/9 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 11 Months | 13 Years 11 Months | ||
Fund AUM | ₹3835 Cr | ₹9479 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.73% | 0.99% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 32 | 38 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 93.27% | 97.32% | ||
Debt % | - | - | ||
P/E | 37.17 | 39.2 | ||
P/B | 5.01 | 5.82 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -3.45% | -2.96% | ||
3-Month Return | 3.21% | 0.79% | ||
6-Month Return | 23.07% | 14.88% | ||
1-Year Return | 15.61% | 12.36% | ||
3-Year Return | 20.7% | 17.62% | ||
5-Year Return | 15.23% | 13.51% |
Sharpe | 0.93 | 0.76 | ||
Alpha | 1.61 | -1.58 | ||
Beta | 0.85 | 0.89 | ||
Standard Deviation | 15.19 | 15.07 | ||
Information Ratio | -0.07 | -0.9 |
Description | DSP Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Chirag Dagli | Amber Singhania, Sailesh Raj Bhan, Kinjal Desai |

